Yesterday, the Supreme Court preserved telehealth and mail access to mifepristone while the legal battle continues. Justices Clarence Thomas and Samuel Alito dissented. The 5th Circuit had ruled on May 1 that the Biden-era FDA regulation allowing the drug to be prescribed by video appointment and mailed to patients without an in-person visit was unlawful. The Supreme Court slapped a temporary stay on that ruling while it considers the case. The fight is live. The stakes are civilizational. . .
